Involvement of gene-specific DNA damage and apoptosis in the differential toxicity of mitomycin C analogs towards B-lineage versus T-lineage lymphoma cells

Biochemical Pharmacology

Volumn 53, Issue 6, 1997, Pages 811-822

  Muscarella, Donna E ^a   Bloom, Stephen E ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b Animal Health Diagnostic Center   (United States)

Author keywords

apoptosis; cross links; DNA; lymphoma cells; mitomycin C; mitomycin C resistance; ribosomal DNA

Indexed keywords

MITOMYCIN C; MITOMYCIN C DERIVATIVE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL LINE; DNA DAMAGE; DRUG SENSITIVITY; IN VITRO STUDY; LYMPHOMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CELL DIVISION; CHICKENS; DNA; DNA DAMAGE; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MITOMYCIN; MITOMYCINS; TUMOR CELLS, CULTURED;

EID: 0030902016     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00009-9     Document Type: Article

References (39)

1. Wyllie AH, Kerr JFR and Currie AR, Cell death: The significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
2. Lerman SP and Weidanz WP, The effect of cyclophosphamide on the ontogeny of the humoral response in chickens. J Immunol 105: 614-619, 1970.
3. Smith PC and Sladek NE, Sensitivity of murine B-and T-lymphocytes to oxazaphosphorine and non-oxazaphosphorine nitrogen mustards. Biochem Pharmacol 34: 3459-3463, 1985.
4. Misra RR and Bloom SE, Roles of dosage, pharmacokinetics, and cellular sensitivity to damage in the selective toxicity of cyclophosphamide towards B and T cells in development. Toxicology 66: 239-256, 1991.
5. Wilmer JL, Colvin OM and Bloom SE, Cytogenetic mechanisms in the selective toxicity of cyclophosphamide analogs and metabolites towards avian embryonic B lymphocytes in vivo. Mutat Res 268: 115-130, 1992.
6. Potchinsky MB, Muscarella DE, Hemendinger RA and Bloom SE, Differential sensitivity of B-lineage lymphocytes compared to T-lineage lymphocytes to mitomycin C-induced DNA damage involving cell cycle inhibition and apoptosis. In Vitro Toxicol 8: 389-402, 1995.
7. Hemendinger RA and Bloom SE, Selective mitomycin C and cyclophosphamide induction of apoptosis in differentiating B lymphocytes compared to T lymphocytes in vivo. Immuno-pharmacology 35: 71-82, 1996.
8. Shirarshi Y, Minowada J and Sandberg AA, Differential response of sister chromatid exchange and chromosome aberrations to mitomycin C of normal and abnormal human lymphocyte cell lines. Oncology 36: 76-83, 1979.
9. Champlin R and Gale RP, Acute lymphoblastic leukemia: Recent advances in biology and therapy. Blood 73: 2051-2066, 1989.
10. Lambe CU, Averett DR, Paff MT, Reardon JE, Wilson JG and Krenitsky TA, Amino-6-methoxyporine arabinoside: An agent for T-cell malignancies. Cancer Res 55: 3352-3356, 1995.
11. Vos J-M and Hanawalt PC, Processing of psoralen adducts in an active human gene repair and replication of DNA containing monoadducts and interstrand cross-links. Cell 50: 789-799, 1987.
12. Islas AL, Vos J-MH and Hanawalt PC, Differential introduction and repair of psoralen photoadducts to DNA in specific human genes. Cancer Res 51: 2867-2873, 1991.
13. Madhani HD, Bohr VA and Hanawalt PC, Differential DNA repair in transcriptionally active and inactive proto-oncogenes: c-abl and c-mos. Cell 45: 417-423, 1986.
14. Venema J, Mullenders LHF, Natarajan AT, Van Zeeland A and Mayne LV, The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced damage in transcriptionally active DNA. Proc Natl Acad Sci USA 87: 4707-4711, 1990.
15. Xu BH and Singh SV, Effect of buthionine sulfoximide and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067. Cancer Res 52: 6666-6670, 1992.
16. Xu BH and Singh SV, Potentiation of mitomycin C cytotoxicity by glutathione depletion in a multi-drug resistant mouse leukemia cell line. Cancer Lett 66: 49-53, 1992.
17. Baba TW, Giroer BP and Humphries EH, Cell lines derived from avian lymphomas exhibit two distinct phenotypes. Virology 144: 139-151, 1985.
18. Okazaki W, Witter RL, Romero C, Nazerian K, Sharma JM, Fadly A and Ewert D, Induction of lymphoid leukosis transplantable tumors and the establishment of lymphoblastoid cell lines. Avian Pathol 9: 311-329, 1980.
19. Moore FR, Schat KA, Hutchison N, Leceil C and Bloom SE, Consistent chromosomal aberration in cell lines transformed with Marek's disease herpesvirus: Evidence of genomic DNA amplification. Int J Cancer 54: 685-692, 1993.
20. Akiyama Y and Kato S, Two cell lines from lymphomas of Marek's disease. Biken J 17: 105-116, 1974.
21. Schat KS, Pratt WD, Morgan R, Weinstock D and Calnek BW, Stable transfection of reticuloendotheliosis virustransformed lymphoblastoid cell lines. Avian Dis 36: 432-439, 1992.
22. Muscarella DE, Vogt VM and Bloom SE, Characterization of ribosomal RNA synthesis in a gene dosage mutant: The relationship of topoisomerase I and chromatin structure to transcriptional activity. J Cell Biol 105: 1501-1513, 1987.
23. Misra RR and Vos J-MH, Defective replication of psoralen adducts detected at the gene-specific level in xeroderma pigmentosum variant cells. Mol Cell Biol 13: 1002-1012, 1993.
24. Dusre L, Rajagopalan S, Eliot HM, Covey JM and Sinha BK, DNA interstrand cross-link and free radical formation in a human multidrug-resistant cell line from mitomycin C and its analogs. Cancer Res 50: 648-652, 1990.
25. Silva JM, Khan S and O'Brien PJ, Contrasting molecular cytotoxic mechanisms of mitomycin C and its two analogs, BMY25282 and BMY25067, in isolated rat hepatocytes. Biochem Pharmacol 45: 2303-2309, 1993.
26. Perry RR, Greaves BR, Rasberry U and Barranco SC, Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro. Cancer Res 52: 4608-4612, 1992.
27. Singh SV, Xu BH, Maurya AK and Mian AM, Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry 31: 7879-7888, 1992.
28. Bloom SE, Delany ME and Muscarella DE, Constant and variable features of avian chromosomes. In: Manipulation of the Avian Genome (Eds. Etches RJ and Verrinder Gibbins AM), pp. 39-59. CRC Press, Boca Raton, EL, 1993.
29. 1 to the transcriptionally active regions of rat liver nucleolar chromatin in vivo and in vitro. Carcinogenesis 4: 889-893, 1983.
30. Matsumoto A, Vos J-MH and Hanawalt PC, Repair analysis of mitomycin C-induced DNA crosslinking in ribosomal RNA genes in lymphoblastoid cells from Fanconi's anemia patients. Mutat Res 217: 185-192, 1989.
31. Stevnsner T, May A, Petersen LN, Larminat F, Pirsel M and Bohr VA, Repair of ribosomal RNA genes in hamster cells after UV irradiation, or treatment with cisplatin or alkylating agents. Carcinogenesis 14: 1591-1596, 1993.
32. Boerrigter METI and Vijg J, Induction and disappearance of DNA single-strand breaks in human B and T lymphocytes after exposure to ethylnitrosourea. Mutat Res 255: 49-55, 1991.
33. Boerrigter METI, Mullaart E and Vijg J, Induction and disappearance of DNA strand breaks in human peripheral blood lymphocytes and fibroblasts treated with methyl methanesulfonate. Exp Cell Res 192: 61-66, 1991.
34. Vos J-MH and Wauthier EL, Differential introduction of DNA damage and repair in mammalian genes transcribed by RNA polymerases I and II. Mol Cell Biol 11: 2245-2252, 1991.
35. Wauthier EL, Hanawalt PC and Vos J-MH, Differential repair and replication of damaged DNA in ribosomal RNA genes in different CHO cell lines. J Cell Biochem 43: 173-183, 1990.
36. Potchinsky MB, Selective immunotoxicity of chemicals to differentiating B lymphocytes compared to T lymphocytes: DNA damage and repair and damage response. Ph.D. Thesis, Cornell University, Ithaca, NY, 1993.
37. Anthoney DA, Mcllwrath AJ, Gallagher WM, Edlin ARM and Brown R, Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res 56: 1374-1381, 1996.
38. De Pooter CM, Van Oosterom AT, Scalliet PG, Maes RA and de Bruijn EA, Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts. Biochem Pharmacol 51: 629-634, 1996.
39. Williams GT and Smith CA, Molecular regulation of apoptosis: Genetic controls of cell death. Cell 74: 777-779, 1993.